Cargando…
Radiolabeling Strategies for Tumor-Targeting Proteinaceous Drugs
Owing to their large size proteinaceous drugs offer higher operative information content compared to the small molecules that correspond to the traditional understanding of druglikeness. As a consequence these drugs allow developing patient-specific therapies that provide the means to go beyond the...
Autores principales: | Sugiura, Grant, Kühn, Helen, Sauter, Max, Haberkorn, Uwe, Mier, Walter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6271853/ https://www.ncbi.nlm.nih.gov/pubmed/24552984 http://dx.doi.org/10.3390/molecules19022135 |
Ejemplares similares
-
PSMA as a target for radiolabelled small molecules
por: Eder, Matthias, et al.
Publicado: (2013) -
Synthesis of Peptide Radiopharmaceuticals for the Therapy and Diagnosis of Tumor Diseases
por: Jamous, Mazen, et al.
Publicado: (2013) -
Cancer Stratification by Molecular Imaging
por: Weber, Justus, et al.
Publicado: (2015) -
Miniproteins as Phage Display-Scaffolds for Clinical Applications
por: Zoller, Frederic, et al.
Publicado: (2011) -
Proteinaceous cysteine protease inhibitors
por: Dubin, G.
Publicado: (2005)